 |
|
|
| CLINICAL TRIAL ON LECTRANAL® COMPLETED |
| A double-blind placebo controlled clinical trial confirms efficacy and safety of Lectranal® in treating seasonal allergic rhinitis. |
| Over a period of 6 weeks 78.6% of patients in the Lectranal® group had significant or moderate improvement compared to 38.5% in the placebo group. Lectranal® had statistical significantly better results for several outcome measures in comparison to the placebo. Lectranal® had strong positive effect on the reduction of SARS and Mini RQLQ score as well as on the improvement in individual allergy symptoms. more |
|
|
|
|
|